Acquiring Company
Olympus
Acquired Company
BioProtect
Shinjuku
TZUR IGALInformation TechnologyBiotechnologyHealth CareMedicalMedical DeviceManufacturingBiotechnologyHealth CareDescription
Olympus Corporation has signed a definitive agreement to acquire BioProtect Ltd. for $270 million, enhancing its portfolio in urology and oncology. The acquisition aligns with Olympus' strategy to address unmet medical needs in cancer treatment. BioProtect's innovative Balloon Spacer technology supports better patient outcomes during prostate cancer radiation therapies. The deal is expected to finalize by the end of Q2 2026, pending customary closing conditions.
Quick answer
Olympus is acquiring BioProtect, announced May 26, 2026. Olympus is based in Shinjuku, Tokyo, Japan.
- How much did Olympus pay for BioProtect?
- The deal value was not disclosed.
- What does Olympus do?
- Olympus is passionate about creating customer-driven solutions for the medical industry.
- Where are Olympus and BioProtect based?
- Olympus is based in Shinjuku, Tokyo, Japan. BioProtect is based in TZUR IGAL, Israel.
- Who are the decision-makers at Olympus?
- Fundz holds 2 contacts at Olympus. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Alkem Medtech to acquire majority stake in Occlutech (June 29, 2026)
- Medtronic to acquire SPR Therapeutics for chronic pain care (May 20, 2026)
- Everis Medical acquires Hood Laboratories for growth (May 20, 2026)
- AP Technologies acquires Blueacre Technology for growth (May 19, 2026)
- Advanced Bifurcation Systems Acquires Svelte Medical (April 27, 2026)
- Zimmer Biomet to acquire Iovera for $140M, $140M (July 9, 2026)
Who to call at Olympus, and when
When Olympus changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Olympus raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Olympus, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Olympus. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Olympus makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired BioProtect?
BioProtect was acquired by Olympus, based in Shinjuku. The deal was reported on May 26, 2026. Olympus is passionate about creating customer-driven solutions for the medical industry. Olympus is privately held and operates in Information Technology.
When did Olympus acquire BioProtect?
Olympus's acquisition of BioProtect was reported on May 26, 2026. Olympus Corporation has signed a definitive agreement to acquire BioProtect Ltd. for $270 million, enhancing its portfolio in urology and oncology. The acquisition aligns with Olympus' strategy to address unmet medical needs in cancer treatment. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does BioProtect do?
BioProtect is a technology platform company that provides innovative biodegradable spacing solutions. It is privately held, operating in Manufacturing, and is based in TZUR IGAL.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.